Literature DB >> 2467770

Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines.

A Mackiewicz1, D Schultz, J Mathison, M Ganapathi, I Kushner.   

Abstract

The effects of various cytokines on synthesis and microheterogeneity of carbohydrate structure of alpha 1-proteinase inhibitor (PI) and alpha-fetoprotein (AFP) in the human hepatoma cell lines Hep 3B and Hep G2 were studied. In both lines, crude cytokine preparations from LPS-activated human monocytes (CM) and several cell lines led to increased PI and decreased AFP synthesis, while recombinant interleukin 1 (IL-1), recombinant tumor necrosis factor (TNF) and hepatocyte stimulating factor preparations (HSF) affected AFP but not PI production. Several of the crude cytokine preparations, but not IL-1, TNF, or HSF, caused Hep 3B cells to secrete forms of PI and AFP showing increased reactivity with Con A upon testing by affinity electrophoresis, while decreased reactivity with Con A was seen in these proteins secreted by Hep G2 cells. Determination of molecular size of PI inducing activity in CM showed a sharp peak at about 17 kD while AFP inhibiting activity was present in a very broad range of molecular size fractions maximal at 17-30 kD. Changes in patterns of glycosylation of these proteins were attributable to cytokines of about 30 kD in Hep 3B and 44 kD in Hep G2 cells. These findings demonstrate the existence of a family of glycosylation regulating cytokines, and suggest that distinct mechanisms within hepatocytes, responsive to different cytokines, may lead to increased or decreased Con A binding of glycoproteins and to altered gene expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467770      PMCID: PMC1541879     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  Acute phase proteins as disease markers.

Authors:  I Kushner; A Mackiewicz
Journal:  Dis Markers       Date:  1987-03       Impact factor: 3.434

2.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

3.  Biosynthesis of abnormally glycosylated alpha 1-antitrypsin by a human hepatoma cell line.

Authors:  J Carlson; S Eriksson; R Alm; T Kjellström
Journal:  Hepatology       Date:  1984 Mar-Apr       Impact factor: 17.425

4.  alpha 1-Antitrypsin microheterogeneity. Isolation and physiological significance of isoforms.

Authors:  L Vaughan; M A Lorier; R W Carrell
Journal:  Biochim Biophys Acta       Date:  1982-03-04

5.  Structure of the asparagine-linked sugar chains of alpha-fetoprotein purified from human ascites fluid.

Authors:  H Yoshima; T Mizuochi; M Ishii; A Kobata
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

6.  Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes.

Authors:  L T May; J Ghrayeb; U Santhanam; S B Tatter; Z Sthoeger; D C Helfgott; N Chiorazzi; G Grieninger; P B Sehgal
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

7.  Studies on the oligosaccharide chains of human alpha 1-protease inhibitor. I. Isolation of glycopeptides.

Authors:  T Mega; E Lujan; A Yoshida
Journal:  J Biol Chem       Date:  1980-05-10       Impact factor: 5.157

8.  Heterogeneous nature of the acute phase response. Differential regulation of human serum amyloid A, C-reactive protein, and other acute phase proteins by cytokines in Hep 3B cells.

Authors:  M K Ganapathi; D Schultz; A Mackiewicz; D Samols; S I Hu; A Brabenec; S S Macintyre; I Kushner
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

9.  Variations in the relative proportions of microheterogeneous forms of plasma glycoproteins in pregnancy and disease.

Authors:  J Raynes
Journal:  Biomed Pharmacother       Date:  1982-03       Impact factor: 6.529

10.  Evidence for alpha-1-acid glycoprotein populations of different pI values after concanavalin A affinity chromatography. Study of their evolution during inflammation in man.

Authors:  I Nicollet; J P Lebreton; M Fontaine; M Hiron
Journal:  Biochim Biophys Acta       Date:  1981-04-28
View more
  13 in total

1.  Second Jenner international glycoimmunology meeting.

Authors: 
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

2.  Changes in the serum concentration and the glycosylation of human alpha 1-acid glycoprotein and alpha 1-protease inhibitor in severely burned persons: relation to interleukin-6 levels.

Authors:  O Pos; M E van der Stelt; G J Wolbink; M W Nijsten; G L van der Tempel; W van Dijk
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  Transforming growth factor beta 1 influences glycosylation of alpha 1-protease inhibitor in human hepatoma cell lines.

Authors:  A Mackiewicz; I Kushner
Journal:  Inflammation       Date:  1990-10       Impact factor: 4.092

4.  Glycosylation Profiling of Glycoproteins Secreted from Cultured Cells Using Glycan Node Analysis and GC-MS.

Authors:  Jesús S Aguilar Díaz de León; Chad R Borges
Journal:  Methods Mol Biol       Date:  2021

5.  Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum?

Authors:  E C Havenaar; R J Dolhain; G A Turner; M T Goodarzi; E C van Ommen; F C Breedveld; W van Dijk
Journal:  Glycoconj J       Date:  1997-06       Impact factor: 2.916

6.  Microheterogeneity of alpha 1 acid glycoprotein in rheumatoid arthritis: dependent on disease duration?

Authors:  P Hrycaj; M Sobieska; S Mackiewicz; W Müller
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

7.  Alpha 1-acid glycoprotein expression in human leukocytes: possible correlation between alpha 1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis.

Authors:  T Nakamura; P G Board; K Matsushita; H Tanaka; T Matsuyama; T Matsuda
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

8.  Different capabilities of monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis to induce glycosylation alterations of acute phase proteins in vitro.

Authors:  A Mackiewicz; M Sobieska; M Kapciñska; S H Mackiewicz; K E Wiktorowicz; T Pawłowski
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

9.  Changes in serum glycoprotein glycosylation during experimental inflammation in mice are general, unrelated to protein type, and opposite changes in man and rat: studies on mouse serum alpha 1-acid glycoprotein, alpha 1-esterase, and alpha 1-protease inhibitor.

Authors:  P M Heegaard
Journal:  Inflammation       Date:  1992-12       Impact factor: 4.092

10.  Microheterogeneity of acute phase proteins in patients with clinically active and clinically nonactive osteoarthritis.

Authors:  P Hrycaj; T Stratz; C Kovac; P Mennet; W Müller
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.